Company intelligence / Profile preview

Epividian

Durham, North Carolina, United Statesepividian.com ↗

Ownership: Private
Development stage: Commercial

Overview

Epividian provides healthcare analytics and research services to support clinical practice and research. Their platforms have been used for dozens of studies in multiple therapeutic areas with a focus on observational data analysis and supporting randomized controlled trials. No direct drug development or clinical trial results as they are not a therapeutics company.

Therapeutic areas: GastroenterologyCardiovascularMetabolic DisordersNephrologyDermatologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

GlaxoWellcome/GlaxoSmithKlineBoehringer-IngelheimHoffmann-La RocheUniversity of North Carolina School of Public HealthYale UniversityVeterans Administration

Beyond the preview

Go deeper on Epividian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epividian.

Explore the full profile